Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

INTRODUCTION: The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) were assessed in patients who were chronically infected with hepatitis C virus (HCV) genotype 2. METHODS: A total of 126 patients with chr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Dis Ther
Hlavní autoři: Tada, Toshifumi, Kumada, Takashi, Okushin, Hiroaki, Tani, Joji, Takaguchi, Koichi, Tsutsui, Akemi, Toyoda, Hidenori, Yasuda, Satoshi, Dohmen, Kazufumi, Hiraoka, Atsushi, Michitaka, Kojiro, Nouso, Kazuhiro, Kariyama, Kazuya, Kim, Soo Ryang, Kim, Soo Ki, Fujioka, Shinichi, Mikami, Shigeru, Watanabe, Yuto, Tamai, Tsutomu, Atsukawa, Masanori, Itokawa, Norio, Tanaka, Hironori, Tsuji, Kunihiko, Ishikawa, Toru, Imai, Michitaka, Itobayashi, Ei, Shibata, Hiroshi, Shimada, Noritomo
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954884/
https://ncbi.nlm.nih.gov/pubmed/33141401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00364-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky